clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Translational Research
Protein that Prevents Tau Clearance Linked to AD and Other Tau…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Multimedia
All
Webinars
eBooks
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Precision Medicine
Mainstreaming Precision Oncology
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Sequencing
Whole-Genome Analysis
Whole-Genome Analysis
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Whole-Genome Analysis
Somatic Mutations at Root of Some Cancers Apparent Years Before Onset
February 6, 2020
Whole-Genome Analysis
GeneDx to Develop Clinical Assays Based on Bionano’s Saphyr System
January 6, 2020
Whole-Genome Analysis
UK Joins Biopharmas, Wellcome on £200M Project to Complete UK Biobank...
September 12, 2019
Whole-Genome Analysis
Day Zero Diagnostics Awarded Phase I SBIR Grant for Algorithm Development
July 10, 2019
Whole-Genome Analysis
Seven Bridges to Manage Data for UK Biobank’s WGS Vanguard Phase
June 6, 2019
Whole-Genome Analysis
BGI Americas, AiLife Partner on Clinical WGS Diagnostics for Genetic Disorders
April 3, 2019
Whole-Genome Analysis
Big Data and Clinical Genomics
March 27, 2019
Whole-Genome Analysis
Diploid, Genomenon Launch Rare Disease Diagnostics Collaboration
February 19, 2019
Whole-Genome Analysis
Adding Diversity to the Reference Genome
February 10, 2019
Whole-Genome Analysis
Foundation Medicine Inks $111.5M Genomic Profiling Contract with VA
February 6, 2019
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]](https://www.clinicalomics.com/wp-content/uploads/2019/01/585-218x150.jpeg "Agendia Reports Positive Results in IMPACt Trial for Breast Cancer")
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-218x150.jpeg "Protein that Prevents Tau Clearance Linked to AD and Other Tau Tangle Proteinopathies")
